When Is enough enough? The need for a robust pipeline of high-quality antimalarials.

01 May 2010

Timothy N Wells and Elizabeth M Poll

Discovery Medicine

This article explores the continuing need for new antimalarials in the context of malaria eradication with regard to the key challenges we face – emerging artemisinin resistance, treating different patient groups and the most important species, and blocking transmission – and how the drug discovery and development pipeline is poised to overcome them.